Brandon Baartman, MD
Ophthalmology · Omaha, NENPI 1124464664
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $202,794 of the $225,609 with a category attached, or 89.9%. 31 manufacturers reported payments, led by Beaver-visitec International, Inc. at 47.9% of the total. 2025 is the largest year on record at $135,486, more than ten times the $8,244 reported in 2019. Among ophthalmology clinicians in NE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 263 payments — averaging $857.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Beaver-visitec International, Inc.$108K
- Glaukos Corporation$39K
- Sight Sciences, Inc.$38K
- Rxsight Inc$23K
- Alcon Research LLC$9K
- Alcon$4K
- plus $5K from 25 others
Across 360 payments — averaging $4734.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Rxsight Inc$602K
- Glaukos Corporation$373K
- Oyster Point Pharma, Inc.$241K
- Beaver-visitec International, Inc.$202K
- Bausch & Lomb Americas Inc.$155K
- Alcon Research LLC$87K
- plus $45K from 2 others
What the payments were for
- Consulting fees$202,79490%
- Speaking & faculty fees$4,6152%
- Travel & lodging$2,2081%
- Food & beverage$8,4704%
- Education$480%
- Other$7,4753%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Beaver-visitec International, Inc. | 1 | $108,035 |
| Glaukos Corporation | 56 | $39,343 |
| Sight Sciences, Inc. | 44 | $38,415 |
| Rxsight Inc | 9 | $22,650 |
| Alcon Research LLC | 5 | $8,860 |
| Alcon | 68 | $3,537 |
| NEW World Medical,inc. | 3 | $1,425 |
| AbbVie(2 entities) | 25 | $637 |
| Kowa Pharmaceuticals America, Inc. | 1 | $464 |
| Samsara Vision | 4 | $330 |
| Biotissue Holdings Inc. | 4 | $297 |
| Optos, Inc. | 1 | $185 |
| Hoya Surgical Optics, Inc | 1 | $178 |
| Ocular Therapeutix, Inc. | 3 | $175 |
| Sun Pharmaceutical Industries Inc. | 5 | $162 |
| Aerie Pharmaceuticals, Inc. | 2 | $143 |
| Shire North American Group Inc | 1 | $124 |
| Bausch & Lomb Americas Inc. | 4 | $94 |
| Tarsus Pharmaceuticals, Inc. | 3 | $87 |
| Oyster Point Pharma, Inc. | 3 | $80 |
| Amgen(2 entities) | 4 | $71 |
| Mallinckrodt Hospital Products Inc. | 3 | $70 |
| Rayner Intraocular Lenses Limited | 2 | $49 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $48 |
| Novartis | 2 | $37 |
| Dompe US, Inc. | 2 | $32 |
| Harrow Eye, LLC | 1 | $22 |
| Carl Zeiss Meditec USA, Inc. | 1 | $16 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $15 |
| Omeros Corporation | 1 | $15 |
| Quidel Corporation | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RXSIGHT CONTACT LENS$22,555
- RXSIGHT INJECTOR CARTRIDGE$22,555
- RXSIGHT INJECTOR HANDPIECE$22,555
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$22,555
- RXSIGHT LIGHT ADJUSTABLE LENS (RXLAL)$21,055
- TearCare SmartLid$16,953
- TEARCARE(TM) (2.2) SYSTEM KIT$16,953
- TearCare$16,059
- Epioxa$8,400
- KXL System$5,497
- Travoprost Intraocular Implant - iDose$3,172
- iStent inject W$3,134
- CE-marked KXLA system$2,675
- OMNI$2,500
- Photrexa$1,884
- TEARCARE SYSTEM$1,500
- LIGHT ADJUSTABLE LENS (LAL)$1,500
- iStent inject Trabecular Micro-Bypass System Model G2-M-IS$1,250
- OMNI(R) SURGICAL SYSTEM (US)$1,125
- SION SURGICAL INSTRUMENT$1,125
How this compares
$225,609 in reported general payments places this provider in the 95th percentile of 105 ophthalmology providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Omaha
- Ronald KruegerOmaha$224K
- Lorraine ProvencherOmaha$220K
- Lance KuglerOmaha$41K
- Rao ChunduryOmaha$14K
- Shane HavensOmaha$6K
- Brandon MenkeOmaha$6K
- Sao LiuOmaha$5K
- Michael HalstedOmaha$4K
- Thomas HejkalOmaha$4K
- Sao LiuOmaha$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.